Dried Blood Spots Combined with Ultra-High-Performance Liquid Chromatography-Mass Spectrometry for the Quantification of the Antipsychotics Risperidone, Aripiprazole, Pipamperone, and Their Major Metabolites

2017-08-01

Therapeutic Drug Monitoring , Volume 39 - Issue 4 p. 429- 440

Additional Metadata
Keywords	antipsychotic drugs, autism spectrum disorders, dried blood spots, pharmacokinetics, therapeutic drug monitoring
Persistent URL	doi.org/10.1097/FTD.0000000000000411, hdl.handle.net/1765/100960
Journal	Therapeutic Drug Monitoring
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Tron, C. (Camille), Kloosterboer, S.M. (Sanne M.), van der Nagel, B., Wijma, R., Dierckx, B., Dieleman, G., … Koch, B. (2017). Dried Blood Spots Combined with Ultra-High-Performance Liquid Chromatography-Mass Spectrometry for the Quantification of the Antipsychotics Risperidone, Aripiprazole, Pipamperone, and Their Major Metabolites. Therapeutic Drug Monitoring, 39(4), 429–440. doi:10.1097/FTD.0000000000000411

Publication